You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dihydro-orotate Dehydrogenase (DHODH)

Showing 1 - 25 of 259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Aug 17, 2022

Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in

Recruiting
  • Metabolic-associated Fatty Liver Disease (MAFLD)
    • Esik, Almaty Region, Kazakhstan
    • +6 more
    Oct 3, 2023

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +22 more
    Jan 27, 2023

    Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate

    Not yet recruiting
    • Chronic Viral Hepatitis B With Delta-Agent
      • Esik, Almaty Region, Kazakhstan
      • +6 more
      Oct 3, 2023

      MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

      Not yet recruiting
      • MEN1 Gene Mutation
      • Leflunomide 20 mg
      • Basel, Switzerland
        Unispital Basel
      Nov 1, 2022

      Leukemia Trial in France, United States (BAY2402234)

      Terminated
      • Leukemia
      • Bronx, New York
      • +4 more
      Dec 20, 2021

      COVID-19 Trial in Chertsey (leflunomide)

      Active, not recruiting
      • COVID-19
      • Chertsey, United Kingdom
        Ashford and St Peters Hospital NHS Foundation Trust
      Aug 12, 2021

      Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

      Recruiting
      • Adult Gliomas, Mixed
      • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
      • Magnetic Resonance Image (MRI)
      • San Francisco, California
        University of California, San Francisco
      May 9, 2023

      Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)

      Enrolling by invitation
      • Non-Alcoholic Fatty Liver Disease
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Nov 30, 2023

      Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

      Completed
      • Type 2 Diabetes Mellitus in Obese
      • +2 more
      • Chula Vista, California
        ProSciento
      Jan 26, 2023

      Lymphoma Trial in United States (AG-636)

      Terminated
      • Lymphoma
      • New Haven, Connecticut
      • +5 more
      Aug 21, 2020

      Astrocytoma Trial (Vorasidenib, Pembrolizumab)

      Not yet recruiting
      • Astrocytoma
      • (no location specified)
      Aug 1, 2022

      Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

      Not yet recruiting
      • Melanoma
      • tunlametinib
      • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Aug 15, 2023

      Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Triheptanoin)

      Recruiting
      • Medium-chain Acyl-CoA Dehydrogenase Deficiency
      • Pittsburgh, Pennsylvania
        UPMC Children's Hospital of Pittsburgh
      Sep 27, 2023

      Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

      Recruiting
      • Melanoma (Skin)
      • +3 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Dec 30, 2022

      Lactate Blood Increase, Thiamine Deficiency Trial in Charleroi (Thiamine 500 MG, Placebo)

      Completed
      • Lactate Blood Increase
      • Thiamine Deficiency
      • Thiamine 500 MG
      • Placebo
      • Charleroi, Hainaut, Belgium
        CHU-Charleroi Hopital Civil Marie Curie
      Nov 16, 2022

      Recurrent High Grade Glioma Trial (MVR-C5252)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • MVR-C5252
      • (no location specified)
      Nov 6, 2023

      Medium-chain Acyl-CoA Dehydrogenase Deficiency Trial in Pittsburgh (Sodium phenylbutyrate)

      Recruiting
      • Medium-chain Acyl-CoA Dehydrogenase Deficiency
      • Sodium phenylbutyrate
      • Pittsburgh, Pennsylvania
        UPMC Children's Hospital of Pittsburgh
      Oct 4, 2023

      International Study of Inflammation in COVID-19

      Recruiting
      • Covid19
      • +4 more
      • SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
      • Ann Arbor, Michigan
        University of Michigan
      Aug 17, 2022

      Relapsing-Remitting Multiple Sclerosis (RRMS) Trial in Worldwide (IMU-838 (30 mg/day), IMU-838 (45 mg/day), Placebo)

      Active, not recruiting
      Has Results
      • Relapsing-Remitting Multiple Sclerosis (RRMS)
      • IMU-838 (30 mg/day)
      • +3 more
      • Blagoevgrad, Bulgaria
      • +37 more
      Jan 19, 2022

      Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood

      Recruiting
      • Sickle Cell Disease Without Crisis
      • G6PD Deficient Red Blood Cell Transfusion
      • Non-G6PD deficient Red Blood Cell Transfusion
      • Chapel Hill, North Carolina
        University of North Carolina at Chapel Hill
      Aug 15, 2022

      Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype Trial in Calgary (Niacin CRT)

      Recruiting
      • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
      • Niacin CRT
      • Calgary, Alberta, Canada
        Tom Baker Cancer Centre
      Jul 18, 2022

      Vivax Malaria, G6PD Deficiency Trial in Hanura, Labuhanbatu, Mimika (Revised case management package)

      Not yet recruiting
      • Vivax Malaria
      • G6PD Deficiency
      • Revised case management package
      • Hanura, Lampung, Indonesia
      • +5 more
      May 18, 2023

      Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

      Active, not recruiting
      • Leukemia, Myeloid
      • Isocitrate Dehydrogenase
      • Los Angeles, California
      • +145 more
      Jun 7, 2022

      Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

      Active, not recruiting
      • Leukemia, Myeloid, Acute
      • Duarte, California
      • +72 more
      Aug 18, 2022